Lanzamiento Enero 2027

Ensayo controlado aleatorizado2019

A Mediterranean Diet Rich in Extra-Virgin Olive Oil Is Associated with a Reduced Prevalence of Nonalcoholic Fatty Liver Disease in Older Individuals at High Cardiovascular Risk

Pintó X, Fanlo-Maresma M, Corbella E, Corbella X, Mitjavila MT, Moreno JJ, Casas R, Estruch R, Corella D, Bulló M, Ruiz-Canela M, Castañer O, Martinez JA, Ros E, PREDIMED Study Investigators

The Journal of nutrition · 77 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
No se indica

Quién lo pagó

Financiación
Financiación independiente
Universidad u hospital
Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición
Gobierno
Instituto de Salud Carlos III
Gobierno
CIBER de Fisiopatología de la Obesidad y Nutrición
Subvenciones
Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición (CB12/03/); Instituto de Salud Carlos III (PI13/01123); Instituto de Salud Carlos III (CB06/03/0028); Instituto de Salud Carlos III (RD06/0045); Instituto de Salud Carlos III (JR14/00008); Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición (CB06/03); Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición (CB06/03/0028); Instituto de Salud Carlos III (CB06/03); Instituto de Salud Carlos III (RD06/0045/0007); Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición (PI13/01123); Instituto de Salud Carlos III (CB12/03/30012)

Según 3 financiadores declarados.

Publicación

Publicado
2019-06-06 · J Nutr · vol. 149 · número 11 · págs. 1920–1929
Editorial
Elsevier BV
Citado
101 citas · más que el 99% de estudios similares · 10.6× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
46 trabajos
Acceso
Lectura gratuita
Áreas de investigación
Nutritional Studies and Diet · Liver Disease Diagnosis and Treatment · Alcohol Consumption and Health Effects
Palabras clave
Mediterranean diet, extra virgin olive oil, non-alcoholic fatty liver disease, hepatic steatosis, liver fat, mixed nuts, cardiovascular risk, type 2 diabetes, omega-3 fatty acids, PREDIMED trial, dietary intervention, older adults, adiposity, glycemic control
MeSH
liver, humans, nuts, cardiovascular diseases, magnetic resonance imaging, diet, fat-restricted, prevalence, risk factors, primary prevention, diet, mediterranean, aged, middle aged, spain, female, male, non-alcoholic fatty liver disease, olive oil

14 autores

  • Xavier Pintó🇪🇸 · autor de correspondenciaInstituto de Salud Carlos III; Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition; Bellvitge University Hospital; Institut d'Investigació Biomédica de Bellvitge
  • Marta Fanlo‐Maresma🇪🇸Bellvitge University Hospital; Institut d'Investigació Biomédica de Bellvitge
  • Emili Corbella🇪🇸Instituto de Salud Carlos III; Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition; Bellvitge University Hospital; Institut d'Investigació Biomédica de Bellvitge
  • Xavier Corbella🇪🇸Bellvitge University Hospital; Universitat Internacional de Catalunya; Institut d'Investigació Biomédica de Bellvitge
  • Maria Teresa Mitjavila🇪🇸Universitat de Barcelona
  • Juan Jose Moreno🇪🇸Instituto de Salud Carlos III; Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition; Universitat de Barcelona
  • Rosa Mª Casas🇪🇸Instituto de Salud Carlos III; Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition; Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
  • Ramón Estruch🇪🇸Instituto de Salud Carlos III; Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition; Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
  • Dolores Corella🇪🇸Universitat de València; Instituto de Salud Carlos III; Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition
  • Mònica Bulló🇪🇸Instituto de Salud Carlos III; Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition; Institut de Recerca Biomèdica Catalunya Sud; Hospital Universitari Sant Joan de Reus; Universitat Rovira i Virgili
  • Miguel Ruiz‐Canela🇪🇸Instituto de Salud Carlos III; Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition; Universidad de Navarra
  • Olga Castañer🇪🇸Instituto de Salud Carlos III; Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition; Hospital del Mar Research Institute
  • J. Alfredo Martinez🇪🇸Instituto de Salud Carlos III; Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition; Bellvitge University Hospital; Institut d'Investigació Biomédica de Bellvitge; IMDEA Food; Universidad de Navarra
  • Emilio Ros🇪🇸Instituto de Salud Carlos III; Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition; Hospital Clínic de Barcelona; Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Adherence to a Mediterranean diet (MedDiet) is thought to reduce liver steatosis.

Objectives

To explore the associations with liver steatosis of 3 different diets: a MedDiet + extra-virgin olive oil (EVOO), MedDiet + nuts, or a control diet.

Methods

This was a subgroup analysis nested within a multicenter, randomized, parallel-group clinical trial, PREvención con DIeta MEDiterránea (PREDIMED trial: ISRCTN35739639), aimed at assessing the effect of a MedDiet on the primary prevention of cardiovascular disease. One hundred men and women (mean age: 64 ± 6 y), at high cardiovascular risk (62% with type 2 diabetes) from the Bellvitge-PREDIMED center were randomly assigned to a MedDiet supplemented with EVOO, a MedDiet supplemented with mixed nuts, or a control diet (advice to reduce all dietary fat). No recommendations to lose weight or increase physical activity were given. Main measurements were the percentage of liver fat and the diagnosis of steatosis, which were determined by NMR imaging. The association of diet with liver fat content was analyzed by bivariate analysis after a median follow-up of 3 y.

Results

Baseline adiposity and cardiometabolic risk factors were similar among the 3 treatment arms. At 3 y after the intervention hepatic steatosis was present in 3 (8.8%), 12 (33.3%), and 10 (33.3%) of the participants in the MedDiet + EVOO, MedDiet + nuts, and control diet groups, respectively (P = 0.027). Respective mean values of liver fat content were 1.2%, 2.7%, and 4.1% (P = 0.07). A tendency toward significance was observed for the MedDiet + EVOO group compared with the control group. Median values of urinary 12(S)-hydroxyeicosatetraenoic acid/creatinine concentrations were significantly (P = 0.001) lower in the MedDiet + EVOO (2.3 ng/mg) than in the MedDiet + nuts (5.0 ng/mg) and control (3.9 ng/mg) groups. No differences in adiposity or glycemic control changes were seen between groups.

Conclusions

An energy-unrestricted MedDiet supplemented with EVOO, a food with potent antioxidant and anti-inflammatory properties, is associated with a reduced prevalence of hepatic steatosis in older individuals at high cardiovascular risk.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.